4682-36-4Cc1ccccc1C(OCC[NH+](C)C)c1ccccc1.O=C([O-])CC(O)(CC(=O)O)C(=O)OMMMNTDFSPSQXJP-UHFFFAOYSA-NSee also: Orphenadrine Citrate (preferred); Orphenadrine (has active moiety); Aspirin; caffeine; orphenadrine citrate (component of).
White Solid
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
용도Muscle relaxant (skeletal); antihistaminic
일반 설명Orphenadrine citrate, N,Ndimethyl-2-(o-methyl-α-phenylbenzyloxy)ethylamine citrate(1:1) (Norflex), introduced in 1957, is closely related todiphenhydramine structurally but has much lower antihistaminicactivity and much higher anticholinergic action.Likewise, it lacks the sedative effects characteristic ofdiphenhydramine. Pharmacological testing indicates that itis not primarily a peripherally acting anticholinergic becauseit has only weak effects on smooth muscle, on the eye,and on secretory glands. It does reduce voluntary musclespasm, however, by a central inhibitory action on cerebralmotor areas, a central effect similar to that of atropine.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…
4682-36-4、4724-58-7정의ChEBI: A citrate salt which comprises equimolar amounts of orphenadrine and citric acid.